跳至主要内容
临床试验/IRCT201104166201N1
IRCT201104166201N1已完成3 期

Effect of zinc and omega-3 supplements in children with attention-deficit hyperactivity disorder

Department of Education and Research of Arak University of Medical Sciences0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 years 至 15 years(—)
性别
All

入选标准

  • 1. Age: 6-15 years, 2. Newly diagnosed patient, 3. No history of taking any psychiatric drug, 4. No other psychiatric disorders, 5. There is no contraindication for the use of zinc and omega 3, 6. Diagnosis of ADHD is based on diagnostic criteria in DSM IV and diagnostic interview of psychiatrist. Exclusion criteria: 1. Parents or children withdrew the study because of any reason, 2. Child is suffering from acute physical illness, 3. Children can’t use oral drugs, 4. Complications of drugs is so high that we have to stop them, 5. Alter treatment, 6. The drug is not used, 7. Any previous psychiatric disorders, 8. Mental retardation, 9. The patient can’t use drugs.

排除标准

  • 未提供

研究者

发起方
Department of Education and Research of Arak University of Medical Sciences

相似试验